Skip to content
Clinical Trials for Alzheimer's Disease

Utah

Alzheimer's disease clinical trials in Utah

7 Alzheimer's disease studies are recruiting participants at sites in 2 cities across Utah as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Utah city with a recruiting study

Salt Lake City (5), Provo (2).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Utah

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Salt Lake City
    Registry record
    NCT07011732 · updated
  2. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    • Phase 4
    • Ages 50 and older
    • All sexes
    Sponsor
    Alpha Cognition, Inc
    Recruiting in
    Provo
    Registry record
    NCT07633470 · updated
  3. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Recruiting in
    Provo
    Registry record
    NCT06808984 · updated
  4. Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

    • No phase
    • Ages 70 and older
    • All sexes
    Sponsor
    University of Michigan
    Recruiting in
    Salt Lake City
    Registry record
    NCT05929703 · updated
  5. Transforming Maternal Mental Health Care

    • No phase
    • Ages 18 to 45
    • Female participants
    Sponsor
    University of Utah
    Recruiting in
    Salt Lake City
    Registry record
    NCT07766174 · updated
  6. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Recruiting in
    Salt Lake City
    Registry record
    NCT06563895 · updated
  7. Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood

    • No phase
    • Ages 25 to 55
    • All sexes
    Sponsor
    University of Utah
    Recruiting in
    Salt Lake City
    Registry record
    NCT07681401 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Utah on ClinicalTrials.gov.

Ask about studies in Utah

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call